ChromaDex (CDXC)
(Delayed Data from NSDQ)
$3.39 USD
-0.01 (-0.29%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $3.40 +0.01 (0.29%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth C Momentum B VGM
Income Statements
Fiscal Year end for ChromaDex Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 84 | 72 | 67 | 59 | 46 |
Cost Of Goods | 33 | 29 | 26 | 24 | 21 |
Gross Profit | 51 | 43 | 41 | 35 | 26 |
Selling & Adminstrative & Depr. & Amort Expenses | 56 | 61 | 69 | 55 | 57 |
Income After Depreciation & Amortization | -6 | -19 | -27 | -20 | -31 |
Non-Operating Income | 1 | 2 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 1 |
Pretax Income | -5 | -17 | -27 | -20 | -32 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -5 | -17 | -27 | -20 | -32 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -5 | -17 | -27 | -20 | -32 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -5 | -18 | -26 | -19 | -29 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 2 |
Income After Depreciation & Amortization | -6 | -19 | -27 | -20 | -31 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 74.99 | 69.73 | 67.19 | 61.07 | 57.06 |
Diluted EPS Before Non-Recurring Items | -0.07 | -0.27 | -0.40 | -0.33 | -0.52 |
Diluted Net EPS (GAAP) | -0.07 | -0.24 | -0.40 | -0.33 | -0.56 |
Fiscal Year end for ChromaDex Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 21.20 | 19.50 | 20.32 | 22.56 |
Cost Of Goods | NA | 8.26 | 7.53 | 7.97 | 9.04 |
Gross Profit | NA | 12.94 | 11.97 | 12.36 | 13.52 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 13.11 | 13.12 | 14.68 | 15.48 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -0.17 | -1.15 | -2.32 | -1.96 |
Non-Operating Income | NA | 0.28 | 0.19 | 0.13 | 0.07 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 0.11 | -0.96 | -2.19 | -1.90 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 0.11 | -0.96 | -2.19 | -1.90 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 0.11 | -0.96 | -2.19 | -1.90 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 75.12 | 75.05 | 74.97 | 74.80 |
Diluted EPS Before Non-Recurring Items | NA | 0.00 | -0.01 | -0.03 | -0.03 |
Diluted Net EPS (GAAP) | NA | 0.00 | -0.01 | -0.03 | -0.03 |